/content/dam/www/people-profile-photos/t/scott-tykodi/provider-scott-tykodi-directory-1x.jpg
/content/dam/www/people-profile-photos/t/scott-tykodi/provider-scott-tykodi-directory-2x.jpg
Tykodi
Scott S. Tykodi, MD, PhD

Scott S. Tykodi, MD, PhD

Medical Oncology

  • Physician, Fred Hutch
  • Professor, Clinical Research Division, Fred Hutch
  • Affiliate Investigator, Translational Science and Therapeutics Division, Fred Hutch
  • Associate Professor, Division of Hematology and Oncology, University of Washington School of Medicine
Request an Appointment

About

Dr. Scott S. Tykodi is a board-certified medical oncologist and researcher at Fred Hutch who treats kidney and skin cancers and leads clinical trials developing immunotherapies. 

Background

Dr. Tykodi’s clinical work is closely integrated with his research, which focuses on translating immunotherapy advances from the lab into patient care for the treatment of kidney and skin cancers.

Dr. Tykodi is involved in the clinical application and translational study of natural and induced T cell immunotherapies that target renal cell carcinoma, kidney cancer and melanoma. His research includes leading clinical trials of novel immune based treatments and developing a new cellular immunotherapy for kidney cancer aimed at the 5T4 marker, a protein found on the surface of most kidney cancer cells and rarely on healthy adult cells. His work aims to bring promising immune therapies more quickly and effectively to patients.

Area of Clinical Practice
Kidney cancer, skin cancers

“I believe patient education is a critical part of cancer care. Knowledge is power.”

— Dr. Tykodi

What's the focus of your work?

I’m a medical oncologist who treats patients with kidney cancer and melanoma. I’m particularly interested in the application of immune therapies to treat cancer. At Fred Hutch, we aim to give you access to promising new treatments like these by offering you the option to participate in clinical trials. We want to present these opportunities to you right away, instead of having you wait. In the past, it could take days for newly diagnosed patients to obtain opinions from multiple specialists. Now we’re hopeful you can get all the information you need in a single visit to the Kidney Cancer Multispecialty Clinic or the Multidisciplinary Skin Oncology Clinic to begin making informed decisions about your care. After helping to design your initial treatment plan, I continue working closely with your other specialists to provide coordinated care throughout your time as a patient.

What’s your approach to my care?

My goal is to keep you in control of your cancer journey. I believe patient education is a critical part of cancer care. Knowledge is power. What I love about working at Fred Hutch is our multidisciplinary clinic. You’re anxious to be seen as quickly as possible. By having specialists work together, we’re accelerating timelines. In a single appointment, you’re evaluated by me or another medical oncologist, a urologist and a radiation oncologist. Receiving opinions from three specialty providers in real time is a great advantage for you and your referring physician, because a comprehensive treatment plan is laid out very quickly. With this streamlined approach, we hope you’ll know of every available treatment option from your very first visit.

Diseases Treated

Kidney Cancer

Melanoma

Languages

English

Education and Experience

Fellowship, Medical Oncology and Hematology-Oncology, University of Washington

Residency, Internal Medicine, Barnes Jewish Hospital

MD, Washington University School of Medicine

Board Certifications

Medical Oncology, 2013, 2003, American Board of Internal Medicine

Clinical Trials

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians and researchers. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your physician can decide if a study is right for you. 

Find a Clinical Trial Led by Dr. Tykodi

Publications

Many of our Fred Hutch physicians and researchers conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch physician has written. 

View Dr. Tykodi's Publications

Your Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders. 

Meet Other Providers

Insurance

Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

More About Insurance

Stories

All news
Kuni Foundation awards $7M to drive adult oncology research forward
Kuni Foundation awards $7M to drive adult oncology research forward Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies June 30, 2025
Kidney cancer: Multidisciplinary clinic helps navigate changing treatment landscape
Kidney cancer: Multidisciplinary clinic helps navigate changing treatment landscape August 31, 2021

Contact Information